Methods	An unblinded parallel trial. Method of generation of randomization list and allocation concealment not stated
Participants	Adults with newly diagnosed epilepsy. Number randomized = PHB group = 30 people; PHT group = 30 people. 100% of participants had partial epilepsy. Range of follow-up not mentioned. Percentage of participants that were male was not stated. Age range: 18-40 years.
Interventions	Monotherapy with PHB or PHT. Dose achieved not stated.
Outcomes	Proportion of completers achieving 24-month remission at 3 years. Proportion of post randomization exclusions due to adverse effects or no efficacy
Notes	Abstract only. Outcomes chosen for this review were not reported. IPD pledged, but not yet received.
Risk of bias
Item	Authors’ judgement	Description
Allocation concealment?	Unclear	B - Unclear